Cargando…
India’s efforts to achieve 1.5 billion COVID-19 vaccinations: a narrative review
The initial case of coronavirus disease 2019 (COVID-19) in India was reported on January 30, 2020, and subsequently, the number of COVID-19-infected patients surged during the first wave of April 2020 and the second wave in the same month of 2021. The government of India imposed a strict nationwide...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korea Disease Control and Prevention Agency
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633268/ https://www.ncbi.nlm.nih.gov/pubmed/36328236 http://dx.doi.org/10.24171/j.phrp.2022.0104 |
_version_ | 1784824226434252800 |
---|---|
author | Singh, Kapil Verma, Ashwani Lakshminarayan, Monisha |
author_facet | Singh, Kapil Verma, Ashwani Lakshminarayan, Monisha |
author_sort | Singh, Kapil |
collection | PubMed |
description | The initial case of coronavirus disease 2019 (COVID-19) in India was reported on January 30, 2020, and subsequently, the number of COVID-19-infected patients surged during the first wave of April 2020 and the second wave in the same month of 2021. The government of India imposed a strict nationwide lockdown in April 2020 and extended it until May 2020. The second wave of COVID-19 in India overwhelmed the country’s health facilities and exhausted its medical and paramedical workforce. This narrative review was conducted with the aim of summarizing the evidence drawn from policy documents of governmental and non-governmental organizations, as well as capturing India's COVID-19 vaccination efforts. The findings from this review cover the Indian government's vaccination initiatives, which ranged from steps taken to combat vaccine hesitancy to vaccination roadmaps, deployment plans, the use of digital health technology, vaccination monitoring, adverse effects, and innovative strategies such as Har Ghar Dastak and Jan Bhagidari Andolan (people’s participation). These efforts collectively culminated in the successful administration of more than 1.8 billion doses of COVID-19 vaccines in India. This review also provides insights into other countries’ responses to COVID-19 and guidance for future pandemics. |
format | Online Article Text |
id | pubmed-9633268 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Korea Disease Control and Prevention Agency |
record_format | MEDLINE/PubMed |
spelling | pubmed-96332682022-11-16 India’s efforts to achieve 1.5 billion COVID-19 vaccinations: a narrative review Singh, Kapil Verma, Ashwani Lakshminarayan, Monisha Osong Public Health Res Perspect Review Article The initial case of coronavirus disease 2019 (COVID-19) in India was reported on January 30, 2020, and subsequently, the number of COVID-19-infected patients surged during the first wave of April 2020 and the second wave in the same month of 2021. The government of India imposed a strict nationwide lockdown in April 2020 and extended it until May 2020. The second wave of COVID-19 in India overwhelmed the country’s health facilities and exhausted its medical and paramedical workforce. This narrative review was conducted with the aim of summarizing the evidence drawn from policy documents of governmental and non-governmental organizations, as well as capturing India's COVID-19 vaccination efforts. The findings from this review cover the Indian government's vaccination initiatives, which ranged from steps taken to combat vaccine hesitancy to vaccination roadmaps, deployment plans, the use of digital health technology, vaccination monitoring, adverse effects, and innovative strategies such as Har Ghar Dastak and Jan Bhagidari Andolan (people’s participation). These efforts collectively culminated in the successful administration of more than 1.8 billion doses of COVID-19 vaccines in India. This review also provides insights into other countries’ responses to COVID-19 and guidance for future pandemics. Korea Disease Control and Prevention Agency 2022-10 2022-10-14 /pmc/articles/PMC9633268/ /pubmed/36328236 http://dx.doi.org/10.24171/j.phrp.2022.0104 Text en © 2022 Korea Disease Control and Prevention Agency. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). |
spellingShingle | Review Article Singh, Kapil Verma, Ashwani Lakshminarayan, Monisha India’s efforts to achieve 1.5 billion COVID-19 vaccinations: a narrative review |
title | India’s efforts to achieve 1.5 billion COVID-19 vaccinations: a narrative review |
title_full | India’s efforts to achieve 1.5 billion COVID-19 vaccinations: a narrative review |
title_fullStr | India’s efforts to achieve 1.5 billion COVID-19 vaccinations: a narrative review |
title_full_unstemmed | India’s efforts to achieve 1.5 billion COVID-19 vaccinations: a narrative review |
title_short | India’s efforts to achieve 1.5 billion COVID-19 vaccinations: a narrative review |
title_sort | india’s efforts to achieve 1.5 billion covid-19 vaccinations: a narrative review |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633268/ https://www.ncbi.nlm.nih.gov/pubmed/36328236 http://dx.doi.org/10.24171/j.phrp.2022.0104 |
work_keys_str_mv | AT singhkapil indiaseffortstoachieve15billioncovid19vaccinationsanarrativereview AT vermaashwani indiaseffortstoachieve15billioncovid19vaccinationsanarrativereview AT lakshminarayanmonisha indiaseffortstoachieve15billioncovid19vaccinationsanarrativereview |